Page last updated: 2024-08-22

trimethaphan and Cardiac Septal Defect

trimethaphan has been researched along with Cardiac Septal Defect in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BERGOUIGNAN, F; LENEGRE, J; RENAIS, J; SCEBAT, L1
Brusan, LA; Panichkin, IuV; Shubin, MK1

Other Studies

2 other study(ies) available for trimethaphan and Cardiac Septal Defect

ArticleYear
[INDICATIONS AND RESULTS OF SURGICAL TREATMENT OF INTERVENTRICULAR COMMUNICATIONS WITH MARKED PULMONARY ARTERIAL HYPERTENSION].
    Archives des maladies du coeur et des vaisseaux, 1964, Volume: 57

    Topics: Cardiac Surgical Procedures; Heart Septal Defects; Heart Septal Defects, Ventricular; Humans; Hypertension; Hypertension, Pulmonary; Mortality; Oxygen; Preoperative Care; Thoracic Surgery; Trimethaphan; Vascular Resistance

1964
[Effect of arfonad on hemodynamics of patients with septal heart defects].
    Grudnaia khirurgiia (Moscow, Russia), 1974, Issue:6

    Topics: Cardiac Catheterization; Heart; Heart Septal Defects; Hemodynamics; Humans; Pulmonary Circulation; Trimethaphan

1974